BioSpace News Archive

Neosanté Health Solutions raises awareness for babies and newborns suffering from episodes of irritability, agitation and crying for National Breastfeeding Awareness Month in August.

Top-line Results of Dose-Escalation Part to be Presented at ESMO 2018 Congress

BioCryst Pharmaceuticals, Inc. announced that the Company has been granted Fast Track Designation by the U.S. Food and Drug Administration (FDA) for BCX7353 for the prevention of angioedema attacks in patients with hereditary angioedema (HAE).

Limited Market Release expands the utility of the XCOIL® for Deep Vein Thrombosis

Harpoon Therapeutics, today that the first patient has been treated with HPN424 in a Phase 1 clinical study of metastatic castration-resistant prostate cancer patients.

Applied BioMath announced an extension to their collaboration with Northern Biologics Inc. to include Phase I clinical analyses for MSC-1, their lead antibody therapeutic targeting the cytokine LIF for the treatment of cancer.

Laboratoris Sanifit S.L., a clinical-stage biopharmaceutical company focused on treatments for calcification disorders, today announced the completion of enrollment of its Phase 2b CaLIPSO clinical trial investigating Sanifit’s lead candidate SNF472, for the treatment of cardiovascular calcification (CVC) in end-stage-renal-disease (ESRD) patients on haemodialysis (HD).

Luminex Corporation announced financial results for the second quarter of 2018. Financial and operating highlights for the quarter

Initiated ADVANCE Phase 3 Program for Ralinepag in Pulmonary Arterial Hypertension (PAH)

Second Quarter Highlights